These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11899622)

  • 1. Safety issues in scale-up of chemical processes.
    Stoessel F
    Curr Opin Drug Discov Devel; 2001 Nov; 4(6):834-9. PubMed ID: 11899622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical process research and development in the 21st century: challenges, strategies, and solutions from a pharmaceutical industry perspective.
    Federsel HJ
    Acc Chem Res; 2009 May; 42(5):671-80. PubMed ID: 19338294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Searching for scalable processes: addressing the challenges in times of increasing complexity.
    Federsel HJ
    Curr Opin Drug Discov Devel; 2003 Nov; 6(6):838-47. PubMed ID: 14758755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A risk we have to swallow: can we ever be sure that medicines are safe before they hit the market?
    Matthews R
    New Sci; 2005 Mar 5-11; 185(2489):23. PubMed ID: 15839012
    [No Abstract]   [Full Text] [Related]  

  • 5. Perspectives on plasmid-based gene therapy: challenges for the product and the process.
    Kelly WJ
    Biotechnol Appl Biochem; 2003 Jun; 37(Pt 3):219-23. PubMed ID: 12672266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous processes for the production of pharmaceutical intermediates and active pharmaceutical ingredients.
    LaPorte TL; Wang C
    Curr Opin Drug Discov Devel; 2007 Nov; 10(6):738-45. PubMed ID: 17987525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innovative oxidation methods in fine chemicals synthesis.
    Poechlauer P; Skranc W
    Curr Opin Drug Discov Devel; 2002 Nov; 5(6):1000-8. PubMed ID: 12478730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
    Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
    Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compound scale-up at the discovery-development interface.
    Nikitenko AA
    Curr Opin Drug Discov Devel; 2006 Nov; 9(6):729-40. PubMed ID: 17117683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The US drug safety system: role of the pharmaceutical industry.
    Gibson BR; Suh R; Tilson H
    Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):110-4. PubMed ID: 17724741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future of toxicology--low-dose toxicology and risk--benefit analysis.
    Rietjens IM; Alink GM
    Chem Res Toxicol; 2006 Aug; 19(8):977-81. PubMed ID: 16918235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timely synthetic support for medicinal chemists.
    Potoski J
    Drug Discov Today; 2005 Jan; 10(2):115-20. PubMed ID: 15718160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biocatalysis: synthesis of chiral intermediates for drugs.
    Patel RN
    Curr Opin Drug Discov Devel; 2006 Nov; 9(6):741-64. PubMed ID: 17117684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Principles of risk assessment for determining the safety of chemicals: recent assessment of residual solvents in drugs and di(2-ethylhexyl) phthalate.
    Hasegawa R; Koizumi M; Hirose A
    Congenit Anom (Kyoto); 2004 Jun; 44(2):51-9. PubMed ID: 15198717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating process safety with molecular modeling-based risk assessment of chemicals within the REACH regulatory framework: benefits and future challenges.
    Lewis A; Kazantzis N; Fishtik I; Wilcox J
    J Hazard Mater; 2007 Apr; 142(3):592-602. PubMed ID: 16930827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New opportunities for biocatalysis: making pharmaceutical processes greener.
    Woodley JM
    Trends Biotechnol; 2008 Jun; 26(6):321-7. PubMed ID: 18436317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico methods for early toxicity assessment.
    Merlot C
    Curr Opin Drug Discov Devel; 2008 Jan; 11(1):80-5. PubMed ID: 18175270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biocatalysis for pharmaceutical intermediates: the future is now.
    Pollard DJ; Woodley JM
    Trends Biotechnol; 2007 Feb; 25(2):66-73. PubMed ID: 17184862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control and analysis of alkyl esters of alkyl and aryl sulfonic acids in novel active pharmaceutical ingredients (APIs).
    Elder DP; Teasdale A; Lipczynski AM
    J Pharm Biomed Anal; 2008 Jan; 46(1):1-8. PubMed ID: 18053672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.